FDA approves Actavis, Valeant drugs for irritable bowel syndrome

May 27, 2015 9:06 PM

42 0

WASHINGTON U.S. health regulators approved new irritable bowel syndrome drugs from Actavis Plc and Valeant Pharmaceuticals International Inc on Wednesday, validating big investments both companies made to acquire the products.

The Food and Drug Administration approved eluxadoline, to be sold under the brand name Viberzi, which Actavis obtained with its $1.1 billion acquisition last year of Furiex Pharmaceuticals.

Read more

To category page